Literature DB >> 2065704

Evaluation of bioequivalence studies.

A P Grieve.   

Abstract

Mesh:

Year:  1991        PMID: 2065704     DOI: 10.1007/BF00280080

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.

Authors:  J E GRIZZLE
Journal:  Biometrics       Date:  1965-06       Impact factor: 2.571

Review 2.  Review of methods and criteria for the evaluation of bioequivalence studies.

Authors:  G Pabst; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  A two-stage procedure for bioequivalence studies.

Authors:  A Racine-Poon; A P Grieve; H Flühler; A F Smith
Journal:  Biometrics       Date:  1987-12       Impact factor: 2.571

4.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

5.  Bayesian approach to bioequivalence assessment: an example.

Authors:  H Fluehler; A P Grieve; D Mandallaz; J Mau; H A Moser
Journal:  J Pharm Sci       Date:  1983-10       Impact factor: 3.534

6.  Comparison of different methods for decision-making in bioequivalence assessment.

Authors:  D Mandallaz; J Mau
Journal:  Biometrics       Date:  1981-06       Impact factor: 2.571

7.  A Bayesian analysis of the two-period crossover design for clinical trials.

Authors:  A P Grieve
Journal:  Biometrics       Date:  1985-12       Impact factor: 2.571

8.  On Bayesian methods for bioequivalence.

Authors:  M R Selwyn; N R Hall
Journal:  Biometrics       Date:  1984-12       Impact factor: 2.571

9.  A Bayesian approach to bioequivalence for the 2 x 2 changeover design.

Authors:  M R Selwyn; A P Dempster; N R Hall
Journal:  Biometrics       Date:  1981-03       Impact factor: 2.571

10.  A non-parametric confidence interval method.

Authors:  A Racine-Poon; A P Grieve
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.